SCHEMBL6640353

SCHEMBL6640353

CCOC(OCC)c1cc(O)nc(SCc2ccc3ccccc3c2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DAO P14920 1/20 0.41
▸ CYP1A2 P05177 2/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ CYP2E1 P05181 1/20 0.38
▸ CYP2C8 P10632 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2B6 P20813 1/20 0.38
▸ CYP2A6 P11509 1/20 0.37
▸ PDE7A Q13946 1/20 0.35
▸ ADORA3 P0DMS8 4/20 0.35
▸ DCUN1D1 Q96GG9 2/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ THRB P10828 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5634282 0.88 RAB9A (0.44) ADORA3NPC1HPGDRAB9ASMN1; SMN2
SCHEMBL6634792 0.76 ALDH1A1 (0.44) DAOCYP1A2CYP2A6NPC1HPGD
SCHEMBL6643920 0.75 RAB9A (0.56) DAOCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL6639377 0.74 DAO (0.47) DAOCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL114060 0.73 RAB9A (0.62) ADORA3NPC1HPGDRAB9ASMN1; SMN2
SCHEMBL114057 0.73 RAB9A (0.44) CYP1A2CYP2C9CYP2C19ADORA3NPC1
SCHEMBL6639172 0.72 CXCR2 (0.47) DAOCYP1A2PDE7ANPC1RAB9A
SCHEMBL6639145 0.71 CYP1A2 (0.48) DAOCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL9092866 0.71 DAO (0.49) DAOCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL6635400 0.70 L3MBTL1 (0.45) DAOCYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0824524-B1 ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE UPJOHN CO (US) 2004-09-08 — — EP disclosed
EP-0824524-A1 ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE PHARMACIA & UPJOHN COMPANY (US) 1998-02-25 — — EP disclosed
WO-1996035678-A1 ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE PHARMACIA & UPJOHN COMPANY (US) 1996-11-14 — — WO disclosed
Send feedback